XDx Announces Highmark's Coverage of AlloMap(R) for Monitoring Heart …MarketWatch (press release)Highmark considers AlloMap "medically necessary" for monitoring heart transplant rejection, recognizing the clinical benefits of a non-inva…
Top Q3 2011 Healthcare Stocks of This Popular Investment FundWall St. Cheat SheetThe Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and ps…
IDIX, DWA, ALXN, HAS, CSIQ – Stocks to watch at NASDAQRetirement Planning… development and commercialization of therapeutic products aimed at treating patients with severe and life-threatening disease states, including those in the therapeutic areas …
Earnings Look Back: Bristol-Myers Squibb Is Down 5.0% Since Reporting …Financial News Network OnlineThe Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transp…
RTT NewsFDA touts number of drugs approved in FY 2011Nurse.comAlmost half of the drugs were judged to be significant therapeutic advances over existing therapies for myocardial infarction, stroke and kidney transplant rejection. • Ten are for rare or…
Bristol-Myers Squibb (BMY) Breaks Through Support at $31.43Financial News Network OnlineThe Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection…
NASDAQ Friday Volume Active Stocks are – ALXN, ICLK, ILMN, AAWW, CSTRRetirement Planning… development and commercialization of therapeutic products aimed at treating patients with severe and life-threatening disease states, including those in the the…
Proactive Investors USA & CanadaBristol-Myers Squibb near SupportTradersHuddle.comThe Company offers products and experimental therapies to address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection a…
RTT NewsFDA Says It's Approving Lots of New DrugsNational Journal“Almost half of the drugs were judged to be significant therapeutic advances over existing therapies for heart attack, stroke, and kidney transplant rejection. Ten are for rare or &…
AFFX, AKAM, AKRX, ALSK, ALXN – Stocks with potential upsideRetirement Planning… development and commercialization of therapeutic products aimed at treating patients with severe and life-threatening disease states, including those in the therapeutic a…